Creating Treatments For Muscular Diseases
Myostin Therapeutics is a privately funded biotechnology company focused on developing novel therapeutic interventions for the treatment of muscular diseases. Our ultimate mission is to be diligent and prompt in producing a treatment for those suffering from physical weakness and frailty. Our commercial strategy is based on our unique proprietary inhibitors’ technologies. We are currently applying our unique myostatin antagonist technology to focus on developing a new drug to treat Duchenne Muscular Dystrophy.